ICD-10-CM Billable Code

N42.32

Atypical small acinar proliferation of prostate

Clinical Classification Guidelines

Medical Intelligence & Overview

Atypical small acinar proliferation of the prostate, classified under ICD-10 code N42.32, is a condition identified through prostate biopsy findings. It indicates the presence of abnormal but not definitively cancerous cells in the prostate gland. This diagnosis often prompts further investigation to determine whether the atypical cells are a precursor to prostate cancer or benign.

Causes & Symptoms

Clinical Causes: Unknown precise cause, but influenced by genetic factors Age-related changes in prostate tissue Inflammation or infection leading to cellular changes Hormonal influences affecting prostate cell growth Proliferative conditions that may mimic early cancer

Key Symptoms: Often asymptomatic; may have no noticeable symptoms Urinary issues such as difficulty starting or stopping urination Frequent urination, especially at night Weak urine flow or a feeling of incomplete bladder emptying Persistent pain or discomfort in the pelvic area

Diagnostic & Treatment

Diagnosis Path: The diagnosis of atypical small acinar proliferation of the prostate is typically made through a prostate biopsy, where tissue samples are examined under a microscope. Findings show small clusters of acinar cells with abnormal features that are not conclusively cancer or benign. Because the appearance can resemble early cancer, further testing like MRI scans or repeat biopsies might be recommended to clarify the diagnosis.

Treatment Protocols: Management strategies may vary depending on individual circumstances. In many cases, active surveillance with regular monitoring is preferred, especially if the atypical finding is limited and the risk of progression is low. Additional assessments like PSA testing or imaging studies may be part of ongoing evaluation. If there is concern about potential cancer development, treatment options could include targeted therapy, surgical intervention, or radiation therapy, decided in consultation with a healthcare professional.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N42.32 a billable ICD-10 code?
Yes, N42.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N42.32?
Clinical documentation must specify the nature of Atypical small acinar proliferation of prostate and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

small atypical prostate proliferation acinar